Related Experiment Video
Updated: Jun 16, 2026
09:17
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
Metabolic Inhibitors and their Impact on Cancer Cell Migration, Invasion, and Metastasis.
Y Stepanov1, Y Yakshibaeva1, V Semenkova2
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv, Ukraine.
Experimental Oncology
|June 15, 2026
Summary
Targeting cancer cell metabolism, specifically the interplay between glycolysis and mitochondria, offers a promising strategy to inhibit metastasis. Understanding these pathways can lead to new anti-cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Metabolic Research
Background:
- Cancer metastasis is the primary cause of cancer mortality.
- Metastatic cells exhibit altered metabolism, including the Warburg effect (increased glycolysis).
- Mitochondria are crucial for tumor progression and metastasis, not just dysfunctional in cancer.
Purpose of the Study:
- To review the mechanisms of glycolysis and oxidative phosphorylation (OXPHOS) inhibitors in cancer.
- To explore the impact of targeting glycolysis-mitochondria crosstalk on cancer cell migration, invasion, and metastasis.
- To assess the therapeutic potential of these metabolic inhibitors against metastasis.
Main Methods:
- Review of existing literature on cancer metabolism and metastasis.
- Analysis of studies investigating glycolysis inhibitors.
- Examination of research on OXPHOS inhibitors and their effects on cancer cell behavior.
Main Results:
- Metastatic cancer cells display metabolic plasticity, utilizing both glycolysis and mitochondrial respiration.
- Inhibitors of glycolysis and OXPHOS can impede cancer cell migration and invasion.
- Targeting the crosstalk between glycolysis and mitochondria shows potential for anti-metastatic strategies.
Conclusions:
- The Warburg effect and mitochondrial activity are critical for cancer cell dissemination.
- Targeting the metabolic interplay between glycolysis and mitochondria presents a viable therapeutic avenue.
- Further research into glycolysis and OXPHOS inhibitors could yield novel anti-metastatic treatments.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...